In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging

Before studying the impact of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) imaging with a dual-head coincidence gamma camera (DHC) for the follow-up of animal tumor models, we wanted to optimize this technique. Three different animal tumor models (osteosarcoma, melanoma, and breast cancer) were studied af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular imaging and biology 2005-05, Vol.7 (3), p.220-228
Hauptverfasser: Monteil, Jacques, Dutour, Aurélie, Akla, Barbara, Chianéa, Thierry, Le Brun, Valérie, Grossin, Laurent, Paraf, François, Petegnief, Yolande, Vandroux, Jean-Claude, Rigaud, Michel, Sturtz, Franck G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 228
container_issue 3
container_start_page 220
container_title Molecular imaging and biology
container_volume 7
creator Monteil, Jacques
Dutour, Aurélie
Akla, Barbara
Chianéa, Thierry
Le Brun, Valérie
Grossin, Laurent
Paraf, François
Petegnief, Yolande
Vandroux, Jean-Claude
Rigaud, Michel
Sturtz, Franck G
description Before studying the impact of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) imaging with a dual-head coincidence gamma camera (DHC) for the follow-up of animal tumor models, we wanted to optimize this technique. Three different animal tumor models (osteosarcoma, melanoma, and breast cancer) were studied after FDG injection. Dynamic and dual time point FDG/DHC imaging were studied from one hour to five hours postinjection. In vitro tumor cell FDG uptake was assessed in eight different tumor cell lines. In one model (osteosarcoma), tumor growth, lung metastasis emergence, and survival were assessed by classical clinical follow-up and compared to FDG imaging in a control group (n = 6) and in a group treated by endostatin liposome complexes (n = 6). Images obtained five hours after injection were more reliable for tumor growth follow-up than standard images (one hour). In vitro tumor cell FDG uptake confirmed in vivo imaging studies. In eight different tumor cell lines the FDG uptake was higher after five hours incubation than after one hour (p < 0.002). With FDG follow-up, we found that FDG uptake was strongly correlated with survival and that lung metastasis larger than 5 mm could be detected. Using the optimization proposed above, DHC/FDG functional imaging seems to be a powerful tool to study rat tumor models and to help develop novel cancer therapies.
doi_str_mv 10.1007/s11307-005-4115-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754881898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67862929</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-214cc6fd2f24f4f515faaaf64401eb3c492e65f4c09e97c281402be2d64f90f73</originalsourceid><addsrcrecordid>eNp9kc9rFDEUgAex2B_6B3iR4EFPad_LJJnkKK2thUIvehIJ2UyynZKZrMlka_97Z9kFwUNP7x2-98Hja5r3COcI0F0UxBY6CiAoRxRUv2pOUEmgDIC9XnbRSoqyZcfNaSmPANgha980xyg0Ms7kSbO9nch22CYSUozpidYNSYFkO5O5jimTMfU-FvI0zA-E0d6nP8-U0Z_XFNWvEGvKiV7RdawuFX_RVxvpg7c9cWmY3ND7yXmytuNoibOjz5YMo10P0_ptcxRsLP7dYZ41P66_fr_8Ru_ub24vv9xR1wo1U4bcORl6FhgPPAgUwVobJOeAftU6rpmXInAH2uvOMYUc2MqzXvKgIXTtWfN5793k9Lv6MptxKM7HaCefajGd4Eqh0mohP71Iyk5JpplewI__gY-p5mn5YrEB1yA4WyDcQy6nUrIPZpOX1_OzQTC7dmbfziztzK6d2Yk_HMR1Nfr-38UhVvsXCdOTbw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>750490542</pqid></control><display><type>article</type><title>In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Monteil, Jacques ; Dutour, Aurélie ; Akla, Barbara ; Chianéa, Thierry ; Le Brun, Valérie ; Grossin, Laurent ; Paraf, François ; Petegnief, Yolande ; Vandroux, Jean-Claude ; Rigaud, Michel ; Sturtz, Franck G</creator><creatorcontrib>Monteil, Jacques ; Dutour, Aurélie ; Akla, Barbara ; Chianéa, Thierry ; Le Brun, Valérie ; Grossin, Laurent ; Paraf, François ; Petegnief, Yolande ; Vandroux, Jean-Claude ; Rigaud, Michel ; Sturtz, Franck G</creatorcontrib><description>Before studying the impact of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) imaging with a dual-head coincidence gamma camera (DHC) for the follow-up of animal tumor models, we wanted to optimize this technique. Three different animal tumor models (osteosarcoma, melanoma, and breast cancer) were studied after FDG injection. Dynamic and dual time point FDG/DHC imaging were studied from one hour to five hours postinjection. In vitro tumor cell FDG uptake was assessed in eight different tumor cell lines. In one model (osteosarcoma), tumor growth, lung metastasis emergence, and survival were assessed by classical clinical follow-up and compared to FDG imaging in a control group (n = 6) and in a group treated by endostatin liposome complexes (n = 6). Images obtained five hours after injection were more reliable for tumor growth follow-up than standard images (one hour). In vitro tumor cell FDG uptake confirmed in vivo imaging studies. In eight different tumor cell lines the FDG uptake was higher after five hours incubation than after one hour (p &lt; 0.002). With FDG follow-up, we found that FDG uptake was strongly correlated with survival and that lung metastasis larger than 5 mm could be detected. Using the optimization proposed above, DHC/FDG functional imaging seems to be a powerful tool to study rat tumor models and to help develop novel cancer therapies.</description><identifier>ISSN: 1536-1632</identifier><identifier>EISSN: 1860-2002</identifier><identifier>DOI: 10.1007/s11307-005-4115-9</identifier><identifier>PMID: 15912426</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Animals ; Breast cancer ; Cancer therapies ; Cell Line, Tumor ; Diagnostic Imaging ; Disease Models, Animal ; Fluorodeoxyglucose F18 - pharmacology ; Follow-Up Studies ; Gamma Cameras ; Humans ; Neoplasm Metastasis - pathology ; Neoplasm Transplantation ; Neoplasms - diagnosis ; Neoplasms - metabolism ; Neoplasms - pathology ; Rats ; Rats, Sprague-Dawley ; Survival Rate ; Time Factors ; Tumors</subject><ispartof>Molecular imaging and biology, 2005-05, Vol.7 (3), p.220-228</ispartof><rights>Academy of Molecular Imaging 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-214cc6fd2f24f4f515faaaf64401eb3c492e65f4c09e97c281402be2d64f90f73</citedby><cites>FETCH-LOGICAL-c358t-214cc6fd2f24f4f515faaaf64401eb3c492e65f4c09e97c281402be2d64f90f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15912426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monteil, Jacques</creatorcontrib><creatorcontrib>Dutour, Aurélie</creatorcontrib><creatorcontrib>Akla, Barbara</creatorcontrib><creatorcontrib>Chianéa, Thierry</creatorcontrib><creatorcontrib>Le Brun, Valérie</creatorcontrib><creatorcontrib>Grossin, Laurent</creatorcontrib><creatorcontrib>Paraf, François</creatorcontrib><creatorcontrib>Petegnief, Yolande</creatorcontrib><creatorcontrib>Vandroux, Jean-Claude</creatorcontrib><creatorcontrib>Rigaud, Michel</creatorcontrib><creatorcontrib>Sturtz, Franck G</creatorcontrib><title>In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging</title><title>Molecular imaging and biology</title><addtitle>Mol Imaging Biol</addtitle><description>Before studying the impact of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) imaging with a dual-head coincidence gamma camera (DHC) for the follow-up of animal tumor models, we wanted to optimize this technique. Three different animal tumor models (osteosarcoma, melanoma, and breast cancer) were studied after FDG injection. Dynamic and dual time point FDG/DHC imaging were studied from one hour to five hours postinjection. In vitro tumor cell FDG uptake was assessed in eight different tumor cell lines. In one model (osteosarcoma), tumor growth, lung metastasis emergence, and survival were assessed by classical clinical follow-up and compared to FDG imaging in a control group (n = 6) and in a group treated by endostatin liposome complexes (n = 6). Images obtained five hours after injection were more reliable for tumor growth follow-up than standard images (one hour). In vitro tumor cell FDG uptake confirmed in vivo imaging studies. In eight different tumor cell lines the FDG uptake was higher after five hours incubation than after one hour (p &lt; 0.002). With FDG follow-up, we found that FDG uptake was strongly correlated with survival and that lung metastasis larger than 5 mm could be detected. Using the optimization proposed above, DHC/FDG functional imaging seems to be a powerful tool to study rat tumor models and to help develop novel cancer therapies.</description><subject>Animals</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cell Line, Tumor</subject><subject>Diagnostic Imaging</subject><subject>Disease Models, Animal</subject><subject>Fluorodeoxyglucose F18 - pharmacology</subject><subject>Follow-Up Studies</subject><subject>Gamma Cameras</subject><subject>Humans</subject><subject>Neoplasm Metastasis - pathology</subject><subject>Neoplasm Transplantation</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Tumors</subject><issn>1536-1632</issn><issn>1860-2002</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc9rFDEUgAex2B_6B3iR4EFPad_LJJnkKK2thUIvehIJ2UyynZKZrMlka_97Z9kFwUNP7x2-98Hja5r3COcI0F0UxBY6CiAoRxRUv2pOUEmgDIC9XnbRSoqyZcfNaSmPANgha980xyg0Ms7kSbO9nch22CYSUozpidYNSYFkO5O5jimTMfU-FvI0zA-E0d6nP8-U0Z_XFNWvEGvKiV7RdawuFX_RVxvpg7c9cWmY3ND7yXmytuNoibOjz5YMo10P0_ptcxRsLP7dYZ41P66_fr_8Ru_ub24vv9xR1wo1U4bcORl6FhgPPAgUwVobJOeAftU6rpmXInAH2uvOMYUc2MqzXvKgIXTtWfN5793k9Lv6MptxKM7HaCefajGd4Eqh0mohP71Iyk5JpplewI__gY-p5mn5YrEB1yA4WyDcQy6nUrIPZpOX1_OzQTC7dmbfziztzK6d2Yk_HMR1Nfr-38UhVvsXCdOTbw</recordid><startdate>200505</startdate><enddate>200505</enddate><creator>Monteil, Jacques</creator><creator>Dutour, Aurélie</creator><creator>Akla, Barbara</creator><creator>Chianéa, Thierry</creator><creator>Le Brun, Valérie</creator><creator>Grossin, Laurent</creator><creator>Paraf, François</creator><creator>Petegnief, Yolande</creator><creator>Vandroux, Jean-Claude</creator><creator>Rigaud, Michel</creator><creator>Sturtz, Franck G</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>7QP</scope></search><sort><creationdate>200505</creationdate><title>In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging</title><author>Monteil, Jacques ; Dutour, Aurélie ; Akla, Barbara ; Chianéa, Thierry ; Le Brun, Valérie ; Grossin, Laurent ; Paraf, François ; Petegnief, Yolande ; Vandroux, Jean-Claude ; Rigaud, Michel ; Sturtz, Franck G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-214cc6fd2f24f4f515faaaf64401eb3c492e65f4c09e97c281402be2d64f90f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cell Line, Tumor</topic><topic>Diagnostic Imaging</topic><topic>Disease Models, Animal</topic><topic>Fluorodeoxyglucose F18 - pharmacology</topic><topic>Follow-Up Studies</topic><topic>Gamma Cameras</topic><topic>Humans</topic><topic>Neoplasm Metastasis - pathology</topic><topic>Neoplasm Transplantation</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monteil, Jacques</creatorcontrib><creatorcontrib>Dutour, Aurélie</creatorcontrib><creatorcontrib>Akla, Barbara</creatorcontrib><creatorcontrib>Chianéa, Thierry</creatorcontrib><creatorcontrib>Le Brun, Valérie</creatorcontrib><creatorcontrib>Grossin, Laurent</creatorcontrib><creatorcontrib>Paraf, François</creatorcontrib><creatorcontrib>Petegnief, Yolande</creatorcontrib><creatorcontrib>Vandroux, Jean-Claude</creatorcontrib><creatorcontrib>Rigaud, Michel</creatorcontrib><creatorcontrib>Sturtz, Franck G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>MEDLINE - Academic</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Molecular imaging and biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monteil, Jacques</au><au>Dutour, Aurélie</au><au>Akla, Barbara</au><au>Chianéa, Thierry</au><au>Le Brun, Valérie</au><au>Grossin, Laurent</au><au>Paraf, François</au><au>Petegnief, Yolande</au><au>Vandroux, Jean-Claude</au><au>Rigaud, Michel</au><au>Sturtz, Franck G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging</atitle><jtitle>Molecular imaging and biology</jtitle><addtitle>Mol Imaging Biol</addtitle><date>2005-05</date><risdate>2005</risdate><volume>7</volume><issue>3</issue><spage>220</spage><epage>228</epage><pages>220-228</pages><issn>1536-1632</issn><eissn>1860-2002</eissn><abstract>Before studying the impact of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) imaging with a dual-head coincidence gamma camera (DHC) for the follow-up of animal tumor models, we wanted to optimize this technique. Three different animal tumor models (osteosarcoma, melanoma, and breast cancer) were studied after FDG injection. Dynamic and dual time point FDG/DHC imaging were studied from one hour to five hours postinjection. In vitro tumor cell FDG uptake was assessed in eight different tumor cell lines. In one model (osteosarcoma), tumor growth, lung metastasis emergence, and survival were assessed by classical clinical follow-up and compared to FDG imaging in a control group (n = 6) and in a group treated by endostatin liposome complexes (n = 6). Images obtained five hours after injection were more reliable for tumor growth follow-up than standard images (one hour). In vitro tumor cell FDG uptake confirmed in vivo imaging studies. In eight different tumor cell lines the FDG uptake was higher after five hours incubation than after one hour (p &lt; 0.002). With FDG follow-up, we found that FDG uptake was strongly correlated with survival and that lung metastasis larger than 5 mm could be detected. Using the optimization proposed above, DHC/FDG functional imaging seems to be a powerful tool to study rat tumor models and to help develop novel cancer therapies.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>15912426</pmid><doi>10.1007/s11307-005-4115-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1536-1632
ispartof Molecular imaging and biology, 2005-05, Vol.7 (3), p.220-228
issn 1536-1632
1860-2002
language eng
recordid cdi_proquest_miscellaneous_754881898
source MEDLINE; SpringerNature Journals
subjects Animals
Breast cancer
Cancer therapies
Cell Line, Tumor
Diagnostic Imaging
Disease Models, Animal
Fluorodeoxyglucose F18 - pharmacology
Follow-Up Studies
Gamma Cameras
Humans
Neoplasm Metastasis - pathology
Neoplasm Transplantation
Neoplasms - diagnosis
Neoplasms - metabolism
Neoplasms - pathology
Rats
Rats, Sprague-Dawley
Survival Rate
Time Factors
Tumors
title In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A28%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20follow-up%20of%20rat%20tumor%20models%20with%202-deoxy-2-%5BF-18%5Dfluoro-D-glucose/dual-head%20coincidence%20gamma%20camera%20imaging&rft.jtitle=Molecular%20imaging%20and%20biology&rft.au=Monteil,%20Jacques&rft.date=2005-05&rft.volume=7&rft.issue=3&rft.spage=220&rft.epage=228&rft.pages=220-228&rft.issn=1536-1632&rft.eissn=1860-2002&rft_id=info:doi/10.1007/s11307-005-4115-9&rft_dat=%3Cproquest_cross%3E67862929%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=750490542&rft_id=info:pmid/15912426&rfr_iscdi=true